Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,430,877,092
+$1,253,453,458 QoQ
Shares Held
3,694,152
+6.9% QoQ
Ownership
0.392%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#38
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. LLY ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,320,446 | $5,909,959,895 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
39,819,151 | $5,030,751,525 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
3,694,152 | $4,430,877,092 | |
| 4 | JNJ |
Johnson & Johnson
|
15,674,093 | $3,980,749,389 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,611,171 | $2,391,535,466 | |
| 6 | AZN |
Astrazeneca PLC
|
10,177,013 | $1,929,765,193 | |
| 7 | ABBV |
AbbVie Inc.
|
7,114,782 | $1,790,363,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,033,480 | $923,849,108 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,430,877,092 | 3,694,152 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,177,423,634 | 3,454,585 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,235,867,143 | 3,011,005 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $2,318,711,983 | 3,038,941 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,517,943,472 | 3,230,079 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,669,346,888 | 3,232,007 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,835,413,180 | 3,672,815 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,260,975,025 | 3,680,808 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,977,017,992 | 3,288,142 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,450,045,753 | 3,149,321 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,787,915,893 | 3,067,172 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,749,993,698 | 3,258,045 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,855,122,132 | 3,955,653 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,383,686,217 | 4,029,137 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,514,148,091 | 4,138,826 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,570,293,002 | 4,856,326 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,555,771,278 | 4,798,357 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,372,267,277 | 4,791,938 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,456,964,917 | 5,274,654 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,162,739,014 | 5,032,413 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,317,476,007 | 5,740,136 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $1,135,072,167 | 6,075,753 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,090,794,020 | 6,460,519 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $673,960,808 | 4,553,174 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $795,362,449 | 4,844,454 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $757,348,630 | 5,459,549 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||